KOGNITIVNYE NARUShENIYa PRI KhRONIChESKOY IShEMII GOLOVNOGO MOZGA
- Authors: Damulina A.I1, Kadykov A.S1
-
Affiliations:
- Issue: No 10 (2014)
- Pages: 55-61
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287059
- ID: 287059
Cite item
Abstract
Vascular brain lesions are one of the most frequent causes of cognitive impairment, especially in elderly and senile patients. Their severity is variable: from a minimum disorders of higher brain functions to dementia. Currently, the treatment of cognitive dysfunction in vascular cognitive impairment (VCI) includes the use of cholinesterase inhibitors and NMDA (N-methyl-D-aspartate) antagonists. Primary and secondary prevention of SKN is similar to the prevention of stroke [11]. Phenotropil is the one of the most promising drug for the treatment and prevention of the progression of cognitive impairment.
Full Text
References
- Bowler J.V. Vascular cognitive impairment. Neurology Neurosurgery Psychiatry. 2005; 76(Suppl V): 35-44.
- Chui H.C., Victoroff J.I., Margolin D. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992; 42: 473-80.
- Erkinjunnti T., Inzitari D., Pantoni L. Research criteria for subcortical vascular dementia in clinical trials. Journal of Neural Transmission. Supplement. 2000; 59: 23-30
- Portet F., Ousset P.J. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. 2006. doi: 10.1136/jnnp.2005.085332. PMCID: PMC2077456
- Petersen R.C., Smith G.E., Waring S.C., et al. Mild cognitive impairment: clinical characterization and outcome. Archives Neurology. 1999; 56(3): 303-08.
- Grundman M., Petersen R.C., Ferris S.H., et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Archives Neurology. 2004; 61(1): 59-66.
- Tabert M.H., Manly J.J., Liu X. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Archives General Psychiatry. 2006; 63(8): 916-24.
- Wentzel C., Rockwood K., MacKnight C. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001; 57: 714-16.
- Rockwood K., Wentzel C., Hachinski V., et al. Prevalence and outcomes of vascular cognitive impairment. Vascular cognitive impairment investigators of the Canadian study of health and aging. Neurology. 2000; 54: 447-51.
- Geroldi C., Ferrucci L., Bandinelli S. Mild cognitive deterioration with subcortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study). J. American Geriatrics Society. 2003; 51(8): 1064-71.
- Levine D.A., Langa K.M. Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implication; Neurotherapeutics. 2011; 8: 361-73.
- Ferri C.P., Prince M., Brayne C., et al. Global prevalence of dementia: Delphi consensus study. Lancet. 2005; 366: 2112-17.
- O'Brien J.T., Erkinjuntti T., Reisberg B., et al. Vascular cognitive impairment. Lancet. Neurol. 2003; 2: 89-98.
- Gorelick P.B., Scuteri A., Black S.E., et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42: 2672-713.
- Farooq M.U., Gorelick P.B. Vascular Cognitive Impairment. Cardiovascular disease and stroke. 2013; 15: 330.
- Rockwood K., et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005; 173: 489-95.
- Wentzel C., Rockwood K. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001; 57(4): 714-16.
- Petersen R.C. Mild cognitive impairment: where are we? 2005 Alzheimer Dis Assoc Disord. 2005; 19(3): 166-69.
- Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Internal Medicine. 2004; 256: 183-94.
- Roman G.C., Tatemichi T.K., Erkinjuntti T. Vascular dementia: diagnostic criteria for research studies: report of the NINDSAIREN International Workshop. Neurology. 1993; 43: 250-60.
- Pedelty L., Nyenhuis D.L. Vascular Cognitive Impairment Current Treatment Options in Cardiovascular Medicine. 2006; 8: 243-50.
- Wade J., Hachinski V. Revised ischemic score for diagnosing multi-infarct dementia. J. Clin. Psychiatry. 1986; 47: 437-38.
- Nyenhuis D., Gorelick P.B. Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment. J. American Geriatrics Society. 1998; 46: 1437-48.
- Starkstein S.E., Sabe S., Vasquez S., et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke. 1996; 7: 408-14.
- Erkinjuntti T., Gauthier S. The Concept of Vascular Cognitive Impairment Dementia in Clinical Practice. Frontiers in Human Neuroscience. 2009; 24: 79-85.
- Gorelick P.B. Risk factors for dementia and Alzheimer's disease. Stroke. 2004; 35(11 suppl 1): 2620-22.
- Caplan L.R., Schmahmann J.D., Kase C.S., et al. Caudate infarcts. Archives Neurology. 1990; 51: 133-43.
- Anoni J.M., Khateb A., Gramingna S. Chronic cognitive impairment following laterothalamic tract infarcts: a study of 9 cases. Archives Neurology 2003; 60: 1439-43.
- Auchus A., Chen C.P., Sodagar S.N., et al. Single stroke dementia: insights from 12 cases in Singapore. J. Neurology Science. 2002; 203-204: 85-9.
- Benisty S., Gouw A.A., Porcher R. on behalf of the LADIS Study group. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. J. Neurology Neurosurgery Psychiatry. 2009; 80: 478-83.
- Barba R., Martinez-Espinosa S., Rodriguez-Garcia E., Pondal M. Poststroke dementia: clinical features and risk factors. Stroke. 2000; 31: 1494-501.
- Henon H., Durieu, I., Guerouaou D., et al. Poststroke dementia: incidence and relationship to prestrike cognitive decline. Neurology. 2001; 57(12): 16-22.
- Englund E. Neuropathology of white matter lesions on vascular cognitive impairment. Cerebrovascular Diseases. 2002; 13: 11-15.
- Caplan L.R. Binswanger' disease-revisited. Neurology. 1995; 45: 626-33.
- Rosenberg G.A. Inflammation and white matter damage in vascular cognitive impairment. Stroke. 2009; 40: S20-23.
- Adair J.C., Charlie J., Dencoff J.E., et al. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke. 2004; 35: e159-62.
- Simpson J.E., Fernando M.S., Clark L. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and Current Atherosclerosis Reports. 2013; 15: 330 Page 5 of 7, 330.
- Weller R.O., Boche D., Nicoll J.A. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathologica. 2009; 118: 87-102.
- Gurol M.E., Irizarry M.C., Smith E.E., et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology. 2006; 66: 23-9.
- Sim F.J., Zhao C., Penderis J., et al. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neuroscience. 2002; 22: 2451-59.
- Louissaint Jr. A., Rao S., Leventhal C., et al. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron. 2002; 34: 945-60.
- Yamamoto H., Watanabe T., Miyazaki A., et al. High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients J. Neurology Neurosurgery Psychiatry. 2006; 77(6): 714-18.
- Utermann G. Apolipoprotein E polymorphism in health and disease. American Heart J. 1987; 113(2 Part 2): 433-40.
- Mahley R.W., Weisgraber K.H., Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology,including Alzheimeer's disease. Proceedings of the National Academy of Sciences USA. 2006; 103: 5644.
- Hebert R., Lindsay J., Verreault R., Rockwood K., Hill G., Dubois M.F. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke. 2000; 31: 1487-93.
- Baum L., Lam L.C., Kwok T., et al. Apolipoprotein E epsilon4 allele is associated with vascular dementia. Dementia Geriatric Cognitive Disorders. 2006; 22: 301-305.
- Kuller L.H., Lopez O.L., Newman A., et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003; 22: 13-22.
- Rowan E., Morris C.M., Stephens S., et al. Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects > 75 years of age. Stroke. 2005; 36: 1864-68.
- Dichgans M. Cognition in CADASIL. Stroke. 2009; 40: S45-7.
- Gasparovic C., Prestopnik J., Thompson J., et al. 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment. J. Neurology Neurosurgery Psychiatry. 2013.
- Кадыков А.С., Манвелов Л.С., Шахпаронова Н.В. Хронические сосудистые заболевания головного мозга. Дисциркуляторная энцефалопатия. М., 2013. 232 с.
- Амчеславская Е.В., Красноперов Е.Н., Белопасова А.В. Изучение эффективности и безопасности применения Фенотропила у больных пожилого возраста с хронической ишемией головного мозга / I Всероссийский конгресс молодых ученых в области медицины и биологии. Сборник научных трудов / Под ред. В.И. Ахапкиной. М., 2009. С. 10-5.
- Верлан Н.В., Кулинский В.И., Колесниченко Л.С. и др. Изучение эффективности и безопасности применения Фенотропила у больных с дисциркуляторной энцефалопатией II стадии / 1 Всероссийский конгресс молодых ученых в области медицины и биологии. Сборник научных трудов / Под ред. В.И. Ахапкиной. М., 2009. С. 21-3.
- Чичановская Л.В., Бардукова Е.А. Изучение эффективности Фенотропила при хронической ишемии головного мозга / I Всероссийский конгресс молодых ученых в области медицины и биологии. Сборник научных трудов / Под ред. В.И. Ахапкиной. М., 2009. С. 24-9.
- Gorelik P.B., Bowler J.V. Advances in vascular cognitive impairment. Stroke. 2010; 41: 2: 93-8.